{
    "code": "02025298",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025298",
    "time": "2018-01-12 03:29:09",
    "許可證字號": "衛署藥輸字第025298號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/11\/24",
    "發證日期": "99\/11\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202529803",
    "中文品名": "諾比舒冒袪痰液",
    "英文品名": "Robitussin Syrup",
    "適應症": "袪痰。",
    "劑型": "170內服液劑",
    "包裝": "10~4000毫升玻璃瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "主成分略述": [
        "GUAIACOLGLYCERYLETHER(EQTOGUAIFENESIN)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F340005200  INTERPHIL LABORATORIES, INC.",
        "製造廠廠址": "CANLUBANG INDUSTRIAL ESTATE, BO PITTLAND 4025 CABUYAO, LAGUNA PHILIPPINES",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800001420",
            "成分名稱": "GUAIACOL GLYCERYL ETHER (EQ TO GUAIFENESIN)",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020252980001-106-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025298&Seq=003&Type=9"
        },
        {
            "title": "020252980002-106-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025298&Seq=006&Type=8"
        },
        {
            "title": "020252980001-106-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025298&Seq=005&Type=8"
        }
    ]
}